Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OTLK

Outlook Therapeutics

$0.91

-0.1252 (-12.04%)

07:16
05/16/19
05/16
07:16
05/16/19
07:16
Initiation
Outlook Therapeutics initiated at Oppenheimer »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
OTLK

Outlook Therapeutics

$1.59

-0.01 (-0.63%)

07:29
04/22/19
04/22
07:29
04/22/19
07:29
Initiation
Outlook Therapeutics initiated at Ascendiant »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTLK

Outlook Therapeutics

$3.20

-1.4 (-30.43%)

09:13
04/10/19
04/10
09:13
04/10/19
09:13
Syndicate
Outlook Therapeutics 10.34M share Secondary priced at $2.75 »

Oppenheimer acted as lead…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

OTLK

Outlook Therapeutics

$7.29

-0.22 (-2.93%)

08:20
04/01/19
04/01
08:20
04/01/19
08:20
Hot Stocks
Outlook Therapeutics announces FDA acceptance of ONS-5010 IND »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

OTLK

Outlook Therapeutics

$0.96

-0.07 (-6.80%)

09:06
03/15/19
03/15
09:06
03/15/19
09:06
Hot Stocks
Outlook Therapeutics announces 1-for-8 reverse stock split »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 10

    Apr

OTLK

Outlook Therapeutics

$1.03

-0.015 (-1.44%)

06:25
03/07/19
03/07
06:25
03/07/19
06:25
Syndicate
Breaking Syndicate news story on Outlook Therapeutics »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

OTLK

Outlook Therapeutics

$1.07

-0.01 (-0.93%)

08:02
03/05/19
03/05
08:02
03/05/19
08:02
Hot Stocks
Outlook Therapeutics regains compliance with Nasdaq listing requirements »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

OTLK

Outlook Therapeutics

$1.10

0.04 (3.77%)

08:09
03/01/19
03/01
08:09
03/01/19
08:09
Hot Stocks
Outlook Therapeutics submits ONS-5010 IND to FDA »

Outlook Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Over a quarter ago
ONS

Oncobiologics

$0.64

-0.036 (-5.31%)

, OTLK

Outlook Therapeutics

$0.00

(0.00%)

09:19
12/03/18
12/03
09:19
12/03/18
09:19
Hot Stocks
Oncobiologics changes name to Outlook Therapeutics »

Oncobiologics (ONS)…

ONS

Oncobiologics

$0.64

-0.036 (-5.31%)

OTLK

Outlook Therapeutics

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.